Conceptualizing a tool to optimize therapy based on dynamic heterogeneity

Physical Biology

Volumn 9, Issue 6, 2012, Pages

  Liao, David ^a   Estévez Salmerón, Luis ^a   Tlsty, Thea D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BIOLOGICAL MODEL; DRUG ADMINISTRATION; DRUG RESISTANCE; GENE DOSAGE; GENETICS; HUMAN; NEOPLASM; PHENOTYPE; PROBABILITY; STATISTICS;

ANTINEOPLASTIC AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, NEOPLASM; GENE DOSAGE; HUMANS; MARKOV CHAINS; MODELS, BIOLOGICAL; NEOPLASMS; PHENOTYPE; STOCHASTIC PROCESSES;

EID: 84871207230     PISSN: 14783967     EISSN: 14783975     Source Type: Journal    
DOI: 10.1088/1478-3975/9/6/065005     Document Type: Review

References (87)

1. Liao D, Estévez-Salmerón L and Tlsty T D 2012 Generalized principles of stochasticity can be used to control dynamic heterogeneity Phys. Biol. 9 065006
2. Spudich J L and Koshland D E Jr 1976 Non-genetic individuality: chance in the single cell Nature 262 467-71
3. Arkin A, Ross J and McAdams H H 1998 Stochastic kinetic analysis of developmental pathway bifurcation in phage λ-infected Escherichia coli cells Genetics 149 1633-48 (available at http://www.genetics.org/content/149/4/ 1633.long)
4. Niepel M, Spencer S L and Sorger P K 2009 Non-genetic cell-to-cell variability and the consequences for pharmacology Curr. Opin. Chem. Biol. 13 556-61
5. Raj A and van Oudenaarden A 2008 Nature, nurture, or chance: stochastic gene expression and its consequences Cell 135 216-26
6. Schrödinger E 1944 What is Life? The Physical Aspect of the Living Cell (Cambridge: Cambridge University Press)
7. Gillespie D T 1977 Exact stochastic simulation of coupled chemical reactions J. Phys. Chem. 81 2340-61
8. Maheshri N and O'Shea E K 2007 Living with noisy genes: how cells function reliably with inherent variability in gene expression Annu. Rev. Biophys. Biomol. Struct. 36 413-34
9. Bartholomay A F 1958 Stochastic models for chemical reactions: I. Theory of the unimolecular reaction process Bull. Math. Biophys. 20 175-90
10. McAdams H H and Arkin A 1999 It's a noisy business! Genetic regulation at the nanomolar scale Trends Genet. 15 65-69
11. Strogatz S H 1994 Nonlinear Dynamics and Chaos: With Applications to Physics, Biology, Chemistry, and Engineering (Boulder, CO: Westview Press)
12. Boyce W E and DiPrima R C 2001 Elementary Differential Equations and Boundary Value Problems 7th edn (New York: Wiley) pp 532-40
13. Bricmont J 1995 Science of chaos or chaos in science? Ann. NY Acad. Sci. 775 131-75 (available at http://onlinelibrary.wiley.com/doi/10.1111/j.1749-6632. 1996.tb23135.x/abstract)
14. Balázsi G, van Oudenaarden A and Collins J J 2011 Cellular decision making and biological noise: from microbes to mammals Cell 144 910-25
15. Thattai M and van Oudenaarden A 2001 Intrinsic noise in gene regulatory networks Proc. Natl Acad. Sci. USA 98 8614-9
16. Kepler T B and Elston T C 2001 Stochasticity in transcriptional regulation: origins, consequences, and mathematical representations Biophys. J. 81 3116-36
17. Huang S 2009 Non-genetic heterogeneity of cells in development: more than just noise Development 136 3853-62
18. Hammes-Schiffer S and Tully J C 1994 Proton transfer in solution: molecular dynamics with quantum transitions J. Chem. Phys. 101 4657-67
19. Townsend J S 2000 A Modern Approach to Quantum Mechanics (Sausalito, CA: University Science Books)
20. Gillespie D T 2007 Stochastic simulation of chemical kinetics Annu. Rev. Phys. Chem. 58 35-55
21. Bernoulli J 1713 Ars Conjectandi (Basel: Thurneysen Brothers)
22. Bueche F 1982 Principles of Physics 4th edn (New York: McGraw-Hill) pp 316-9
23. Dinov I D, Christou N and Sanchez J 2008 Central limit theorem: new SOCR applet and demonstration activity J. Stat. Educ. 16 1-15 (available at http://www.amstat.org/publications/jse/v16n2/dinov.html)
24. Waks Z and Silver P A 2010 Nuclear origins of cell-to-cell variability Cold Spring Harb. Symp. Quant. Biol. 75 1-8
25. Ozbudak E M, Thattai M, Kurtser I, Grossman A D and van Oudenaarden A 2002 Regulation of noise in the expression of a single gene Nature Genet. 31 69-73
26. Raj A, Peskin C S, Tranchina D, Vargas D Y and Tyagi S 2006 Stochastic mRNA synthesis in mammalian cells PLoS Biol. 4 e309
27. Becskei A, Kaufmann B B and van Oudenaarden A 2005 Contributions of low molecule number and chromsomal positioning to stochastic gene expression Nature Genet. 37 937-44
28. Kalmar T, Lim C, Hayward P, Muñoz-Descalzo S, Nichols J, Garcia-Ojalvo J and Arias M A A 2009 Regulated fluctuations in Nanog expression mediate cell fate decisions in embryonic stem cells PLoS Biol. 7 e1000149
29. Süel G M, Garcia-Ojalvo J, Liberman L M and Elowitz M B 2006 An excitable gene regulatory circuit induces transient cellular differentiation Nature 440 545-50
30. Vilar J M G, Kueh H Y, Barkai N and Leibler S 2002 Mechanisms of noise-resistance in genetic oscillators Proc. Natl Acad. Sci. USA 99 5988-92
31. Brock A, Chang H and Huang S 2009 Non-genetic heterogeneity-a mutation-independent driving force for the somatic evolution of tumours Nature Rev. Genet. 10 336-42
32. Rath H, Tlsty T and Schimke R T 1984 Rapid emergence of methotrexate resistance in cultured mouse cells Cancer Res. 44 3303-6 (available at http://cancerres.aacrjournals.org/content/44/8/3303.short)
33. Engelman J A, Zejnullahu K, Mitsudomi T and Song Y 2007 MET amplification leads to Gefitinib resistance in lung cancer by activating ErbB3 signaling Science 316 1039-43
34. Spencer S L, Gaudet S, Albeck J G, Burke J M and Sorger P K 2009 Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis Nature 459 428-32
35. Chang H H, Hemberg M, Barahona M, Ingber D E and Huang S 2008 Transcriptome-wide noise controls lineage choice in mammalian progenitor cells Nature 453 544-7
36. Silva J and Smith A 2008 Capturing pluripotency Cell 132 532-6
37. Borst P and Cross G A M 1982 Molecular basis for trypanosome antigenic variation Cell 29 291-303
38. Cross G A M 1990 Cellular and genetic aspects of antigenic variation in trypanosomes Annu. Rev. Immunol. 8 83-110
39. Raser J M and O'Shea E K 2005 Noise in gene expression: origins, consequences, and control Science 309 2010-3
40. MacArthur B D, Ma'ayan A and Lemischka I R 2009 Systems biology of stem cell fate and cellular reprogramming Nature Rev. Mol. Cell. Biol. 10 672-81 (available at http://www.nature.com/nrm/journal/v10/n10/full/nrm2766.html)
41. Gupta P B, Fillmore C M, Jiang G, Shapira S D, Tao K, Kuperwasser C and Lander E S 2011 Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells Cell 146 633-44
42. Kittel C and Kroemer H 1980 Thermal Physics 2nd edn (New York: W H Freeman) pp 271 407-8
43. Johnston R N, Beverley S M and Schimke R T 1983 Rapid spontaneous dihydrofolate reductase gene amplification shown by fluorescence-activated cell sorting Proc. Natl Acad. Sci. USA 80 3711-5
44. Sigal A, Milo R, Cohen A, Geva-Zatorsky N, Klein Y, Liron Y, Rosenfeld N, Danon T, Perzov N and Alon U 2006 Variability and memory of protein levels in human cells Nature 444 643-6
45. Iliopoulos D, Hirsch H A, Wang G and Struhl K 2011 Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion Proc. Natl Acad. Sci. USA 108 1397-402
46. Skipper H E, Schabel F M Jr, Mellett L B, Montgomery J A, Wilkoff L J, Lloyd H H and Brockman R W 1970 Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules Cancer Chemother. Rep. 54 431-50 (available at http://www.ncbi.nlm.nih.gov/pubmed?term=skipper%20schabel%201970%20implications)
47. Balaban N Q, Merrin J, Chait R, Kowalik L and Leibler S 2004 Bacterial persistence as a phenotypic switch Science 305 1622-5
48. Sharma S V, Lee D Y, Li B, Quinlan M P, Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L and Fischbach M A 2010 A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations Cell 141 69-80
49. Charlebois D A, Abdennur N and Kaern M 2011 Gene expression noise facilitates adaptation and drug resistance independently of mutation Phys. Rev. Lett. 107 218101
50. Levin B R 2004 Noninherited resistance to antibiotics Science 305 1578-9
51. Dhar N and McKinney J D 2007 Microbial phenotypic heterogeneity and antibiotic tolerance Curr. Opin. Microbiol. 10 30-38
52. Webb G F 1992 A cell population model of periodic chemotherapy treatment Biomedical Modeling and Simulation ed J Eisenfeld, DS Levine and M Witten (Amsterdam: Elsevier) pp 83-92
53. Foo J and Michor F 2009 Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies PLoS Comput. Biol. 5 e1000557
54. Hernández-Bronchud M and Molife R 2002 Pharmacology and principles of high dose chemotherapy High Dose Chemotherapy: Principles and Practice ed P Lorigan and E Vandenberghe (London: Martin Dunitz) pp 15-28
55. Cassidy J 2005 Drug development and study design Cancer Clinical Pharmacology ed J H M Shellens, H L McLeod and D R Newell (Oxford: Oxford University Press) pp 41-50
56. Pui C H and Evans W E 2006 Treatment of acute lymphoblastic leukemia New England J. Med. 354 166-78
57. Kamen B A, Glod J and Cole P D 2006 Metronomic therapy from a pharmacologist's view J. Pediatr. Hematol. Oncol. 28 325-7
58. Kerbel R S and Kamen B A 2004 The anti-angiogenic basis of metronomic chemotherapy Nature Rev. Cancer 4 423-36
59. Seidman A D et al 2008 Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors J. Clin. Oncol. 26 1642-9
60. Camitta B M and Kamen B A 2003 Role of methotrexate in the treatment of acute lymphoblastic leukemia Treatment of Acute Leukemias: New Directions for Clinical Research (Current Clinical Oncology) ed C H Pui (Totowa, NJ: Humana) pp 357-62
61. Klingebiel T et al 2008 Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial Pediatr. Blood Cancer 50 739-45
62. Alvarez A, Mickiewicz E, Brosio C, Giglio R, Cinat G and Suarez A 1998 Weekly taxol (T) in patients who had relapsed or remained stable with T in a 21 day schedule Proc. Am. Soc. Clin. Oncol. 17 A188 (available at http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst-detail- view&confID=31&abstractID=13033)
63. Baltali E, Altundag K, Ozisik Y, Guler N and Tekuzman G 2004 Weekly paclitaxel in pretreated metastatic breast cancer: Retrospective analysis of 52 patients Tohoku J. Exp. Med. 203 205-10
64. Toyoda Y et al 2000 Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood J. Clin. Oncol. 18 1508-16 (available at http://jco.ascopubs.org/content/18/7/1508.long)
65. Möricke A et al 2010 Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000 Leukemia 24 265-84
66. de Bont J M, van der Holt B, Dekker A W, van der Does-van den B A, Sonneveld P and Pieters R 2004 Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands Leukemia 18 2032-5
67. Klement G L and Kamen B A 2011 Nontoxic, fiscally responsible, future of oncology: could it be beginning in the third world? J. Pediatr. Hematol. Oncol. 33 1-3
68. Aguirre-Ghiso J A 2007 Models, mechanisms and clinical evidence for cancer dormancy Nature Rev. Cancer 7 834-46
69. Klein C A 2009 Parallel progression of primary tumours and metastases Nature Rev. Cancer 9 302-12
70. Panetta J C 1997 A mathematical model of breast and ovarian cancer treated with paclitaxel Math. Biosci. 146 89-113
71. Samaga R, Saez-Rodriguez J, Alexopoulos L G, Sorger P K and Klamt S 2009 The logic of EGFR/ErbB signaling: theoretical properties and analysis of high-throughput data PLoS Comput. Biol. 5 e1000438
72. Navin N E and Hicks J 2010 Tracing the tumor lineage Mol. Oncol. 4 267-83
73. Losi L, Baisse B, Bouzourene H and Benhattar J 2005 Evolution of intratumoral genetic heterogeneity during colorectal cancer progression Carcinogenesis 26 916-22
74. Chmielecki J et al 2011 Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling Sci. Transl. Med. 3 90ra59
75. Browder T, Butterfield C E, Kräling B M, Shi B, Marshall B, O'Reilly M S and Folkman J 2000 Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer Cancer Res. 60 1878-86 (available at http://cancerres.aacrjournals.org/content/60/7/1878.long)
76. Michor F, Hughes T P, Iwasa Y, Branford S, Shah N P, Sawyers C L and Nowak M A 2005 Dynamics of chronic myeloid leukemia Nature 435 1267-70
77. Hughes T P et al 2010 Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic meyloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS) Blood 116 3758-65
78. Lardinois D, Weder W, Hany T F, Kamel E M, Korom S, Seifert B, von Schulthess G K and Steinert H C 2003 Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography New England J. Med. 348 2500-7
79. Marom E M, Sarvis S, Herndon J E II and Patz E F 2002 T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET Radiology 223 453-9
80. Satti J 2009 The emerging low-dose therapy for advanced cancers Dose-Response 7 208-20
81. Li K L, Henry R G, Wilmes L J, Gibbs J, Zhu X, Lu Y and Hylton N M 2007 Kinetic assessment of breast tumors using high spatial resolution Signal Enhancement Ratio (SER) imaging Magn. Reson. Med. 58 572-81
82. Nagrath S et al 2007 Isolation of rare circulating tumour cells in cancer patients by microchip technology Nature 450 1235-9
83. Meng S et al 2004 Circulating tumor cells in patients with breast cancer dormancy Clin. Cancer Res. 10 8152-62
84. Duffy M J, Evoy D and McDermott E W 2010 CA 15-3: Uses and limitation as a biomarker for breast cancer Clin. Chim. Acta 411 1869-74
85. Gomella L G, Liu X S, Trabulsi E J, Kelly W K, Myers R, Showalter T, Dicker A and Wender R 2011 Screening for prostate cancer: the current evidence and guidelines controversy Can. J. Urol. 18 5875-83 (available at http://www.canjurol.com/abstract.php?ArticleID=&version=1.0&PMID= 22018148)
86. Zen K and Zhang C Y 2012 Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers Med. Res. Rev. 32 326-48
87. Cerussi A E, Tanamai V W, Mehta R S, Hsiang D, Butler J and Tromberg B J 2010 Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient Acad. Radiol. 17 1031-9